NPTH.V - Biomed/telehealth stock trading below 1x revenues
NPTH is significantly undervalued compared to peers:
- 33M mkt cap with 50M revenue in 2019
- < 1 EV/sales vs 18.24x industry avg
- Recent 12M financing at .90
- Insider options at .87 + open market buys
- In major historical support zone
- 33M mkt cap with 50M revenue in 2019
- < 1 EV/sales vs 18.24x industry avg
- Recent 12M financing at .90
- Insider options at .87 + open market buys
- In major historical support zone
相关出版物
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。